Drug Type Synthetic peptide |
Synonyms |
Mechanism C1R inhibitors(Complement C1r inhibitors), C1S inhibitors(Complement C1s inhibitors), MPO inhibitors(Myeloperoxidase inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ReAlta Life Sciences, Inc.Startup |
Active Organization ReAlta Life Sciences, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Blood Platelet Disorders | Preclinical | US | ReAlta Life Sciences, Inc.Startup | - |